Product Details
| Product Name:
Reglitazar |
CAS No.:
170861-63-9 |
| Purity:
98.72% |
Supply Ability:
10g |
| Release date:
2026/04/20 |
Product Introduction
Bioactivity
| Name | Reglitazar |
| Description | Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Reglitazar | PPARγ | PPARα | PNU716 | PNU 716 | PNU 182716 | JTT 501 |
| Inhibitors Related | PHYTOL | Rosiglitazone | Retinoic acid | Daidzein | Fenofibrate | Magnesium acetate tetrahydrate | Maltitol | Naringenin | 2,3-Butanediol | NPC 15199 | Icariin | Cloxiquine |
| Related Compound Libraries | Nuclear Receptor Compound Library | Ferroptosis Compound Library | Glycometabolism Compound Library | DNA Damage & Repair Compound Library | Bioactive Compound Library | ReFRAME Related Library | Anti-Diabetic Compound Library | Anti-Obesity Compound Library | Metabolism Compound Library | Bioactive Compounds Library Max | Human Metabolite Library | Transcription Factor-Targeted Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States